Epilepsies d'origine auto-immune [Autoimmune epilepsies]

There is increasing recognition of an autoimmune origin of pharmacoresistant epileptic disorders. Besides the paraneoplastic limbic encephalopathies (LE), reports of syndromes of non-paraneoplastic LE are increasingly reported in the last 5-10 years. Three antibodies are now relatively well described: Voltagegated potassium channels (VGKC), Glutamic acid decarboxylase (GAD) and N-methyl-D-apartate receptor-(NMDA) antibodies. We review clinical syndromes, associated imaging and laboratory findings. While most reports arise from adult populations, children and adolescents are also concerned as evidenced by increasing observations. Early recognition is mandatory, since early immunomodulatory treatment appears to be related to significant better outcome.

El mètode APT (Auto Adjusting Perturbation Theory) de diagonalització de matrius

Es presenta un nou algorisme per a la diagonalització de matrius amb diagonal dominant. Es mostra la seva eficàcia en el tractament de matrius no simètriques, amb elements definits sobre el cos complex i, fins i tot, de grans dimensions. Es posa de manifest la senzillesa del mètode així com la facilitat d'implementació en forma de codi de programació. Es comentenels seus avantatges i característiques limitants, així com algunes de les millores que es poden implementar. Finalment, es mostren alguns exemples numèrics

Supervivencia en cáncer de mama tras 10 años de seguimiento en las provincias de Granada y Almería

Background: To describe the overall and disease-free survival at five and ten years after breast cancer diagnosis in women from a previous case-control study, and establish related prognostic factors. Methods: We followed up 202 patients diagnosed between 1996 and 1998 in three public hospitals in Granada and Almeria provinces in Spain. Survival rates were calculated using the Kaplan and Meier method, and the Cox proportional hazards model was applied to identify the most significant variables contributing to survival. Results: Mean age at diagnosis was 54.27±10.4 years. Mean follow-up for overall survival was 119.91 months (95%CI 113.65126.17); the five-year survival rate was 83.9% (95%CI: 78.13-89.66) and the ten-year rate was 71% (95%CI: 63.25-78.74). Mean followup for disease-free survival was 118.75 months (95%CI 111.86125.65); the five-year disease-free survival rate was 81% (95%CI: 74.52-87.47) and the ten-year rate was 71.3% (95%CI: 63.33-79.26). The mortality rate of the study population was 33.17%. Conclusions: Disease characteristics are similar in our population to those in other Spanish and European regions, while the overall survival is higher than the mean rate during the same period in Europe (5-yr rate of 79%) and similar to that in Spain (83%).

Perspectives of auto-correcting lens distortions in mosaic-based underwater navigation

When unmanned underwater vehicles (UUVs) perform missions near the ocean floor, optical sensors can be used to improve local navigation. Video mosaics allow to efficiently process the images acquired by the vehicle, and also to obtain position estimates. We discuss in this paper the role of lens distortions in this context, proving that degenerate mosaics have their origin not only in the selected motion model or in registration errors, but also in the cumulative effect of radial distortion residuals. Additionally, we present results on the accuracy of different feature-based approaches for self-correction of lens distortions that may guide the choice of appropriate techniques for correcting distortions

Alternativas de tratamiento para el cáncer de mama : ¿qué opción prefiero? : instrumento de ayuda para la toma de decisiones

Publicado en la página web de la Consejería de Salud y Bienestar Social: www.juntadeandalucia.es/salud (Consejería de Salud y Bienestar Social / Ciudadanía / Nuestro Compromiso por la Calidad / Guías de información para pacientes). Documento para la ciudadanía relacionado con el Proceso Asistencial Integrado : Cáncer de mama

Monoclonal auto-antibodies and sera of autoimmune patients react with Plasmodium falciparum and inhibit its in vitro growth

The relationship between autoimmunity and malaria is not well understood. To determine whether autoimmune responses have a protective role during malaria, we studied the pattern of reactivity to plasmodial antigens of sera from 93 patients with 14 different autoimmune diseases (AID) who were not previously exposed to malaria. Sera from patients with 13 different AID reacted against Plasmodium falciparum by indirect fluorescent antibody test with frequencies varying from 33-100%. In addition, sera from 37 AID patients were tested for reactivity against Plasmodium yoelii 17XNL and the asexual blood stage forms of three different P. falciparum strains. In general, the frequency of reactive sera was higher against young trophozoites than schizonts (p < 0.05 for 2 strains), indicating that the antigenic determinants targeted by the tested AID sera might be more highly expressed by the former stage. The ability of monoclonal auto-antibodies (auto-Ab) to inhibit P. falciparum growth in vitro was also tested. Thirteen of the 18 monoclonal auto-Ab tested (72%), but none of the control monoclonal antibodies, inhibited parasite growth, in some cases by greater than 40%. We conclude that autoimmune responses mediated by auto-Ab may present anti-plasmodial activity.

Auto-enregistrament del dolor a través de telefonia mòbil per a pacients menors

Aquest projecte s'inclou dins del marc del projecte Fibroline, desenvolupat pel grup de recerca 'Algos' de la Universitat Rovira i Virgili.El projecte Fibroline consisteix en el desenvolupament d'un protocol d'intervenció cognitivo-conductual (TCC) autoadministrat mitjançant tecnologia mòbil intel·ligent, de baix cost, accessible, i eficaç, per a prevenir i/o reduir el dolor i les conseqüències negatives associades amb la fibromiàlgia en adolescents i joves adults.

Hormonoterapia primaria en mujeres añosas con cáncer de mama localizado hormonosensible

Se analizó de forma retrospectiva una serie de pacientes con una edad mediana de 79 años con cáncer de mama localizado, con receptor de estrógeno positivo tratadas con hormonoterapia primaria. Tras recibir el tratamiento primario las pacientes candidatas se sometían a cirugía. La respuesta clínica fue de un 63.6%. La mediana de tiempo a progresión fue de 94 meses y la mediana de la supervivencia global no se alcanzó, siendo la media de 123 meses. Se evaluó el impacto del tratamiento quirúrgico en estos resultados, no objetivándose diferencias estadísticamente significativas. La hormonoterapia exclusiva en casos seleccionados es efectiva y segura

Em busca de uma abordagem não atomizada para o exame das relações entre liderança transformacional e comprometimento organizacional

As pesquisas tradicionais sobre liderança fazem uso de uma abordagem atomizada, que desconsidera os efeitos de diferentes padrões (gestalts) do construto e prioriza a lógica de uma variável por vez. A partir dessa crítica, o objetivo no presente trabalho é analisar a relação de distintas gestalts (configurações) de liderança transformacional com o comprometimento organizacional. Para a consecução desse objetivo, foram analisados 331 questionários de funcionários de oito organizações do setor de serviços. O método de pesquisa é classificado como levantamento (survey), com amostragem não probabilística por conveniência. Para o tratamento dos dados, fez-se uso da técnica de modelagem de equações estruturais no processo de análise da validade e confiabilidade das escalas. Na sequência, a análise de cluster evidenciou três configurações de liderança, denominadas: desorientação, subliderança e conversão. Para a verificação da influência dessas gestalts sobre o comprometimento organizacional, foi testado um modelo linear generalizado - MANCOVA fatorial. Os resultados indicaram a relação entre as configurações de liderança transformacional e as dimensões afetiva, instrumental e normativa do comprometimento; entretanto, para o comprometimento instrumental, a relação é mediada pelo grau de instrução dos liderados. Por fim, são discutidas as implicações dos achados empíricos.

Eficacia de la combinación de Vinorelbine- Trastuzumab en carcinoma de mama metastásico con sobreexpresión de HER2, previamente tratado con Trastuzumab

L'addició de Trastuzumab a quimioteràpia basada en taxans millora la supervivència de les pacients amb carcinoma de mama metastàtic i sobreexpressió de HER2. En el nostre estudi, analitzem l'eficàcia de Vinorelbine-Trastuzumab a la progressió a Trastuzumab. De les 46 pacients analitzades, 26 van realitzar Trastuzumab previ al tractament amb Vinorelbine-Trastuzumab, obtenint un temps lliure de progressió de 6.5 mesos, benefici clínic del 48% i respostes del 27%, similar al descrit pels tractaments aprovats, Capecitabina-Lapatinib i Capecitabina-Trastuzumab. CONCLUSIÓ: Vinorelbine-Trastuzumab en pacients prèviament tractades amb Trastuzumab manté una significativa activitat en càncer de mama metastàtic en progressió a Trastuzumab.